# Karis Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/karis-bio

- Industry: Healthcare
- Headquarters: Seoul, South Korea
- Website: www.karisbio.com
- Total disclosed funding: $17M
- Latest round: Series B (Mar 4, 2025)
- Investors on record: 8

## About

Based in Seoul, South Korea, and founded in 2020, Karis Bio Inc. is a company that develops technology to use cell-based therapy techniques for treatment of cardiovascular diseases. The company was established by Young-Seop Yoon, a professor specializing in the Department of Biomedical Sciences at Yonsei University, who has been focusing on human stem cell and tissue engineering research for the past 20 years. CEO Yoon came to Yonsei University as a special professor since 2015 while serving as a chair professor in the Department of Cardiology and Medical Engineering at Emory University and as the head of the Stem Cell Research Center. In 2020, Karis Bio Inc. has been awarded U-Tech Valley Business by Korea Technology Finance Corporation.

The company develops a technology that differentiates human induced pluripotent stem cells (hiPSCs) into endothelial cells (EC).

## Funding rounds

- Series B, Mar 4, 2025, $7.9M — Korea Development Bank, AJU IB Investment, Premier Partners, Devsisters Ventures, Korea Venture Investment Corporation, Yonsei Technology Holdings, Yonsei Biohealth Technology Holdings
- Series A, Aug 2, 2021, $8.9M — Korea Development Bank, AJU IB Investment, Seoul Investment Partners, Premier Partners, Devsisters Ventures

## Investors

- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series A, Series B
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A, Series B
- Seoul Investment Partners (https://capitalatlas.ai/funds/seoul-investment-partners) — Series A
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A, Series B
- Devsisters Ventures (https://capitalatlas.ai/funds/devsisters-ventures) — Series A, Series B
- Korea Venture Investment Corporation (https://capitalatlas.ai/funds/korea-venture-investment-corporation) — Series B
- Yonsei Technology Holdings (https://capitalatlas.ai/funds/yonsei-technology-holdings) — Series B
- Yonsei Biohealth Technology Holdings — Series B